Meryem Jefferies

692 total citations
17 papers, 411 citations indexed

About

Meryem Jefferies is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Meryem Jefferies has authored 17 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Pharmacology and 3 papers in Infectious Diseases. Recurrent topics in Meryem Jefferies's work include Substance Abuse Treatment and Outcomes (6 papers), Cannabis and Cannabinoid Research (5 papers) and Prenatal Substance Exposure Effects (3 papers). Meryem Jefferies is often cited by papers focused on Substance Abuse Treatment and Outcomes (6 papers), Cannabis and Cannabinoid Research (5 papers) and Prenatal Substance Exposure Effects (3 papers). Meryem Jefferies collaborates with scholars based in Australia, United States and United Kingdom. Meryem Jefferies's co-authors include Harunor Rashid, Bisma Rauff, Shafquat Rafiq, Thao Minh Lam, Nicholas Lintzeris, Adrian Dunlop, Raimondo Bruno, Llewellyn Mills, Jan Copeland and Mark Montebello and has published in prestigious journals such as Addiction, Journal of Medical Internet Research and Drug and Alcohol Dependence.

In The Last Decade

Meryem Jefferies

17 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meryem Jefferies Australia 9 218 155 92 45 44 17 411
Kerstin Käll Sweden 10 170 0.8× 67 0.4× 28 0.3× 46 1.0× 71 1.6× 16 354
Scott L. Letendre United States 13 130 0.6× 63 0.4× 28 0.3× 32 0.7× 270 6.1× 32 656
Daniel Gruener United States 9 155 0.7× 165 1.1× 44 0.5× 18 0.4× 69 1.6× 15 307
John C. Voris United States 9 91 0.4× 61 0.4× 35 0.4× 11 0.2× 66 1.5× 19 344
Reza Imani Iran 10 95 0.4× 49 0.3× 11 0.1× 44 1.0× 38 0.9× 41 391
Giuseppe Pontrelli Italy 16 184 0.8× 28 0.2× 30 0.3× 193 4.3× 99 2.3× 34 807
Des Jarlais United States 8 482 2.2× 96 0.6× 95 1.0× 14 0.3× 343 7.8× 14 681
Anne V. Tuomari United States 14 153 0.7× 25 0.2× 25 0.3× 123 2.7× 100 2.3× 19 640
Michael Murphy United States 9 39 0.2× 23 0.1× 36 0.4× 38 0.8× 26 0.6× 23 238
Nayra Rodríguez Puerto Rico 9 97 0.4× 42 0.3× 25 0.3× 10 0.2× 85 1.9× 21 320

Countries citing papers authored by Meryem Jefferies

Since Specialization
Citations

This map shows the geographic impact of Meryem Jefferies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meryem Jefferies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meryem Jefferies more than expected).

Fields of papers citing papers by Meryem Jefferies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meryem Jefferies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meryem Jefferies. The network helps show where Meryem Jefferies may publish in the future.

Co-authorship network of co-authors of Meryem Jefferies

This figure shows the co-authorship network connecting the top 25 collaborators of Meryem Jefferies. A scholar is included among the top collaborators of Meryem Jefferies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meryem Jefferies. Meryem Jefferies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bryant, Jamie, Megan Freund, Paul Haber, et al.. (2024). Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse. Drug and Alcohol Review. 43(5). 1194–1203. 2 indexed citations
2.
Jefferies, Meryem, Robert Graham, N. Scott Reading, et al.. (2024). Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review. Journal of Medical Internet Research. 26. e46394–e46394. 1 indexed citations
3.
Murnion, Bridin, et al.. (2023). ‘It’s a fragile open door’—enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder. Journal of Public Health. 45(4). e729–e736. 1 indexed citations
4.
Montebello, Mark, Meryem Jefferies, Llewellyn Mills, et al.. (2022). Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial. Drug and Alcohol Dependence. 234. 109388–109388. 4 indexed citations
5.
Mills, Llewellyn, Adrian Dunlop, Mark Montebello, et al.. (2022). Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Substance Abuse Treatment Prevention and Policy. 17(1). 67–67. 6 indexed citations
6.
Jefferies, Meryem, Harunor Rashid, Scott Read, et al.. (2022). COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out. Vaccines. 10(6). 889–889. 5 indexed citations
7.
Mills, Llewellyn, Nicholas Lintzeris, Raimondo Bruno, et al.. (2020). Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and Alcohol Review. 39(4). 356–364. 8 indexed citations
8.
Lintzeris, Nicholas, Llewellyn Mills, Adrian Dunlop, et al.. (2020). Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence. 215. 108220–108220. 25 indexed citations
9.
10.
Lintzeris, Nicholas, Anjali Bhardwaj, Llewellyn Mills, et al.. (2019). Nabiximols for the Treatment of Cannabis Dependence. JAMA Internal Medicine. 179(9). 1242–1242. 62 indexed citations
11.
Lintzeris, Nicholas, Lauren A. Monds, María Carmen Bravo, et al.. (2019). Designing, implementing and evaluating the overdose response with take‐home naloxone model of care: An evaluation of client outcomes and perspectives. Drug and Alcohol Review. 39(1). 55–65. 12 indexed citations
12.
Jefferies, Meryem, Bisma Rauff, Harunor Rashid, Thao Minh Lam, & Shafquat Rafiq. (2018). Update on global epidemiology of viral hepatitis and preventive strategies. World Journal of Clinical Cases. 6(13). 589–599. 214 indexed citations
13.
Jefferies, Meryem, Harunor Rashid, Grant Hill-Cawthorne, & Veysel Kayser. (2018). A Brief History of Ebolavirus Disease: Paving the Way Forward by Learning from the Previous Outbreaks. Infectious Disorders - Drug Targets. 20(3). 259–266. 5 indexed citations
14.
Jefferies, Meryem, et al.. (2013). Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep. Veterinary Immunology and Immunopathology. 155(1-2). 21–29. 15 indexed citations
15.
Gazina, Elena V., et al.. (2005). Ion transport blockers inhibit human rhinovirus 2 release. Antiviral Research. 67(2). 98–106. 17 indexed citations
16.
Keim, T.A., M. Chari, B. Gamble, et al.. (1979). Design studies of superconducting generators. IEEE Transactions on Magnetics. 15(1). 703–710. 17 indexed citations
17.
Jefferies, Meryem, et al.. (1970). New approach to micromachine construction. Proceedings of the Institution of Electrical Engineers. 117(7). 1309–1309. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin Käll Breakdown of academic impact, for papers by Scott L. Letendre Breakdown of academic impact, for papers by Daniel Gruener Breakdown of academic impact, for papers by John C. Voris Breakdown of academic impact, for papers by Reza Imani Breakdown of academic impact, for papers by Giuseppe Pontrelli Breakdown of academic impact, for papers by Des Jarlais Breakdown of academic impact, for papers by Anne V. Tuomari Breakdown of academic impact, for papers by Michael Murphy Breakdown of academic impact, for papers by Nayra Rodríguez
Rankless by CCL
2026